Kaye Edward M. MD bought STOK
October 8, 2025 · Form 4 insider transaction
Kaye Edward M. MD bought 25,000 shares of Stoke Therapeutics, Inc. at $0.60 per share, a transaction worth $15.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.60
Total value
$15.0K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after74,124
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.